A Pilot Study of Bevacizumab-Based Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas.
Phase of Trial: Phase I
Latest Information Update: 07 May 2018
At a glance
- Drugs Bevacizumab (Primary) ; Irinotecan; Temozolomide
- Indications Anaplastic astrocytoma; Glioblastoma; Gliosarcoma
- Focus Adverse reactions
- 01 May 2018 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 28 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Jun 2018.